Hiroshima Biomedical Co, 広島バイオメディカル

[link|313|Hiroshima Biomedical Co website] is a startup company located in Hiroshima. The company was founded in 2007 as a spin-off of Hiroshima University. It develops and sells chicken monoclonal antibodies, transgenic chicken and eggs. Capital is 10 million Yen (~ 89.000 €). It is located in the Hiroshima University Industry Cooperation Center and has 5 employees. President is Mr Haruo MATSUDA.

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny